Trabajamos continuamente para brindarte una mejor experiencia, y decidimos discontinuar esta página. Podrás acceder a contenido similar en Selectores y disfrutar de funcionalidades similares.
19.96k seguidores • 30 símbolos Lista de seguimiento de Yahoo Finance
Follow this list to discover and track stocks with the greatest 52-week loss. These are stocks whose price has increased the most over the past 52 weeks (percent change). This list is generated daily, the losses are based on today\u0027s closing price and limited to the top 30 stocks that meet the criteria.
Selección de Yahoo Finance
Lista de seguimiento | El cambio hoy | Retorno de un mes | Retorno de un año | Retorno total |
---|---|---|---|---|
Largest 52-Week Losses | -1.89% | - | - | - |
^GSPC | -0.29% | +2.12% | +35.64% | +6334.40% |
Símbolo | Nombre de la empresa | Último precio | Cambio | Cambio en % | Tiempo del mercado | Volumen | Volumen promedio (3 meses) | Capitalización bursátil |
---|---|---|---|---|---|---|---|---|
INTC | Intel Corporation | 24.16 | -0.89 | -3.55% | 4:00 p. m. EST | 59.75M | 79.83M | 104.20B |
HUM | Humana Inc. | 280.06 | -2.38 | -0.84% | 4:00 p. m. EST | 1.68M | 2.28M | 33.72B |
STM | STMicroelectronics N.V. | 27.15 | +0.29 | +1.08% | 4:00 p. m. EST | 4.04M | 4.77M | 24.43B |
LI | Li Auto Inc. | 22.61 | -1.72 | -7.07% | 4:00 p. m. EST | 6.64M | 8.74M | 24.23B |
EL | The Estée Lauder Companies Inc. | 62.74 | -1.85 | -2.86% | 4:00 p. m. EST | 5.31M | 4.83M | 22.52B |
PKX | POSCO Holdings Inc. | 53.83 | -1.63 | -2.94% | 4:00 p. m. EST | 379.36k | 219.17k | 16.85B |
MRNA | Moderna, Inc. | 43.47 | +0.72 | +1.68% | 4:00 p. m. EST | 10.69M | 5.55M | 16.73B |
DG | Dollar General Corporation | 75.12 | -1.17 | -1.53% | 4:00 p. m. EST | 4.33M | 5.08M | 16.52B |
MBLY | Mobileye Global Inc. | 16.93 | +0.29 | +1.74% | 4:00 p. m. EST | 6.48M | 6.45M | 13.73B |
DLTR | Dollar Tree, Inc. | 62.27 | +1.06 | +1.73% | 4:00 p. m. EST | 3.55M | 4.68M | 13.39B |
SIRI | Sirius XM Holdings Inc. | 27.16 | -0.28 | -1.02% | 4:00 p. m. EST | 6.39M | 5.91M | 9.21B |
CE | Celanese Corporation | 75.71 | -2.90 | -3.69% | 4:00 p. m. EST | 3.84M | 1.27M | 8.27B |
APA | APA Corporation | 21.87 | -0.30 | -1.35% | 4:00 p. m. EST | 6.88M | 6.12M | 8.09B |
WBA | Walgreens Boots Alliance, Inc. | 9.01 | -0.38 | -4.05% | 4:00 p. m. EST | 22.30M | 21.51M | 7.79B |
LCID | Lucid Group, Inc. | 2.14 | -0.20 | -8.55% | 4:00 p. m. EST | 88.50M | 43.67M | 6.45B |
FLG | Flagstar Financial, Inc. | 11.28 | -0.17 | -1.48% | 4:00 p. m. EST | 5.02M | 6.30M | 4.68B |
FIVE | Five Below, Inc. | 83.26 | +0.26 | +0.31% | 4:00 p. m. EST | 1.96M | 1.83M | 4.58B |
CSAN | Cosan S.A. | 7.87 | -0.20 | -2.48% | 4:00 p. m. EST | 586.17k | 547.93k | 3.73B |
ACHC | Acadia Healthcare Company, Inc. | 40.11 | -1.33 | -3.21% | 4:00 p. m. EST | 1.43M | 1.50M | 3.73B |
XRAY | DENTSPLY SIRONA Inc. | 17.77 | +0.12 | +0.68% | 4:00 p. m. EST | 4.21M | 3.00M | 3.53B |
CAR | Avis Budget Group, Inc. | 99.2 | +2.37 | +2.45% | 4:00 p. m. EST | 759.90k | 657.41k | 3.49B |
SSL | Sasol Limited | 5.36 | -0.20 | -3.60% | 4:00 p. m. EST | 1.32M | 832.69k | 3.39B |
LOT | Lotus Technology Inc. | 4.32 | -0.26 | -5.68% | 4:00 p. m. EST | 118.11k | 115.24k | 3.12B |
CNXC | Concentrix Corporation | 40.72 | -2.22 | -5.17% | 4:00 p. m. EST | 695.71k | 712.48k | 2.78B |
ACLS | Axcelis Technologies, Inc. | 82.73 | -2.60 | -3.05% | 4:00 p. m. EST | 822.03k | 612.00k | 2.77B |
DLO | DLocal Limited | 9.35 | +0.70 | +8.09% | 4:00 p. m. EST | 2.90M | 1.20M | 2.46B |
NFE | New Fortress Energy Inc. | 9.39 | -0.42 | -4.28% | 4:00 p. m. EST | 4.43M | 5.23M | 2.36B |
CPRI | Capri Holdings Limited | 19.39 | -0.55 | -2.76% | 4:01 p. m. EST | 3.42M | 3.72M | 2.29B |
IQ | iQIYI, Inc. | 2.2 | -0.10 | -4.35% | 4:00 p. m. EST | 15.83M | 18.30M | 2.21B |
CXM | Sprinklr, Inc. | 8.21 | -0.08 | -0.97% | 4:00 p. m. EST | 3.70M | 2.03M | 2.08B |
Insight into the Latest 13F Filing for Q3 2024
Novavax sees Sanofi deal as path forward for company into profitability.
The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused trials.